Putative hormone with anti-obesogenic and insulin-sensitizing effect

Int J Immunopathol Pharmacol. 2016 Mar;29(1):147-8. doi: 10.1177/0394632015623796. Epub 2015 Dec 29.

Abstract

It was confirmed that bone morphogenetic protein-9 (BMP-9), like insulin, improves glycemia in diabetic mice and regulates glucose metabolism in hepatocytes, which is why it is proposed as a candidate for the hepatic insulin-sensitizing substance (HISS). Regarding the fact that BMP-9 has a signaling pathway similar to other BMPs as well as insulin, it is expected that BMP-9 would also have certain effects on the liver. In our 2011 hypothesis, we aimed towards BMP-9 as a possible "hepatic insulin-sensitizing substance" (HISS) and in this article, we provide further evidence, derived from existing studies, suggesting that this putative hormone might in fact be none other than BMP-9.

Keywords: BMP-9; NO; endothelium.

Publication types

  • Letter

MeSH terms

  • Gluconeogenesis / drug effects
  • Growth Differentiation Factor 2 / pharmacology*
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Insulin / pharmacology*
  • Nitric Oxide / physiology

Substances

  • Growth Differentiation Factor 2
  • Hypoglycemic Agents
  • Insulin
  • Nitric Oxide